drugset / Trial / NCT00000458

Sertraline and Cognitive Therapy in Depressed Alcoholics

NCT00000458

RandomizedDouble-blindTreatment

Summary

This study will assess whether individuals treated with sertraline (Zoloft) and cognitive behavior therapy will experience improvement with their depression and consume less alcohol than individuals treated with a placebo and cognitive behavior therapy. This is a 12-week, random assignment, placebo-controlled, double-blind study with followup assessments 1 and 3 months after treatment.

Timeline

Start
Primary completion
Completion
2002-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule